Journal profile · PHARMACOLOGY & PHARMACY
American Journal of Therapeutics
ISSN 1075-2765 · eISSN 1536-3686 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1994
American Journal of Therapeutics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.29; hybrid open access; review 6–12 weeks (community reports); community-reported acceptance: easy; 206 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
American Journal of Therapeutics is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Atrial Fibrillation Management and Outcomes, Cardiac electrophysiology and arrhythmias and Poisoning and overdose treatments, together about 18.7% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.
Source: LetPub
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Peter ManuPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Atrial Fibrillation Management and OutcomesMedicine6.7%
- Cardiac electrophysiology and arrhythmiasMedicine6.1%
- Poisoning and overdose treatmentsMedicine5.8%
- Blood Pressure and Hypertension StudiesMedicine5.4%
- Pharmacological Effects and Toxicity StudiesMedicine5.3%
- Venous Thromboembolism Diagnosis and ManagementMedicine5%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine4.5%
- Inflammatory mediators and NSAID effectsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.29LetPub ·
- Impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.5LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 55LetPub ·
- h-index
- 84OpenAlex ·
- i10-index
- 1,367OpenAlex ·
- 2-year mean citedness
- 0.98OpenAlex ·
- Self-citation rate
- 28.6%LetPub ·
- Share of gold OA articles
- 14.66%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 4,410 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 161 | 15 | 16 |
| 2025 | 206 | 7 | 107 |
| 2024 | 174 | 18 | 406 |
| 2023 | 74 | 4 | 225 |
| 2022 | 125 | 10 | 455 |
| 2021 | 159 | 18 | 1,135 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1994
- ISSN
- 1075-2765
- Electronic ISSN
- 1536-3686
- Latest issue on the website
- Volume 33, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about American Journal of Therapeutics
What CAS zone is American Journal of Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, American Journal of Therapeutics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of American Journal of Therapeutics?
The latest impact factor listed by LetPub is 3.29; CiteScore 3.4, h-index 84.
How long does peer review take at American Journal of Therapeutics?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index American Journal of Therapeutics?
According to LetPub and DOAJ records, American Journal of Therapeutics is indexed in SCIE and Scopus.
Is American Journal of Therapeutics open access, and what is the APC?
American Journal of Therapeutics is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .